Adar1 Capital Management, LLC Prothena Corp Public LTD CO Transaction History
Adar1 Capital Management, LLC
- $1.06 Trillion
- Q3 2025
A detailed history of Adar1 Capital Management, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 1,469,098 shares of PRTA stock, worth $15.1 Million. This represents 1.35% of its overall portfolio holdings.
Number of Shares
1,469,098
Previous 3,375,009
56.47%
Holding current value
$15.1 Million
Previous $20.5 Billion
30.01%
% of portfolio
1.35%
Previous 3.14%
Shares
4 transactions
Others Institutions Holding PRTA
# of Institutions
217Shares Held
34.9MCall Options Held
656KPut Options Held
1.12M-
Black Rock Inc. New York, NY3.86MShares$39.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.05MShares$21 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY1.82MShares$18.7 Million0.27% of portfolio
-
Rubric Capital Management LP New York, NY1.54MShares$15.8 Million0.25% of portfolio
-
Palo Alto Investors LP Palo Alto, CA1.32MShares$13.6 Million2.57% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $481M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...